UNSPSC 51442409: Iobitridol

This classification denotes an iodinated contrast dye with the molecular formula C20H28I3N3O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 182ECH14UH, chemically known as 1,3-benzenedicarboxamide, n,n-bis(2,3-dihydroxypropyl)-5-((5-hydroxy-2-(hydroxymethyl)-1-oxopropyl)amino)-2,4,6-triiodo-n,n-dimethyl- but more generally known as iobitridol, which bears U.S. National Institutes of Health Compound Identifier 65985.

UNSPSC 51442409 Iobitridol, a Commodity code, nominally covers a specific radiographic contrast agent, but recent state and local opportunities show little alignment with this narrow pharmaceutical specification. Instead, the recent solicitations under this code cluster around radiologic and X-ray equipment procurement, installation, warranty, and maintenance services — a significant scope drift from the code's stated pharmaceutical product. State and local issuing bodies using this code include county governments (Maricopa County, Escambia County, Broward County, Pasco County in Florida, and Arizona), with issuing departments spanning corrections facilities, aviation departments, and education systems. The work being solicited ranges from capital equipment procurement and installation (radiologic systems for college campuses) to extended warranty coverage for specific X-ray machines and specialized maintenance services for proprietary inspection systems.

Recent opportunities show activity concentrated in Florida and Arizona. Maricopa County issued an IFB (IFB362910) for radiologic equipment and installation at three college locations, with proposals due October 22, 2026. Escambia County Correction solicited an extended warranty (SSCORALM2526005) for X-Ray Machine serial numbers ASTTC160SM4803-4804-4805 under sole-source procurement, with responses due August 19, 2026. Broward County Aviation Department posted an RFI (BLD2132311F1) on June 25, 2026, to determine whether maintenance services for Rapiscan X-ray inspection systems are available from sources other than the sole manufacturer, with responses due July 28, 2026. The code shows activity in state and local procurement but reflects equipment-and-services work rather than pharmaceutical supply — a mismatch between code classification and actual buying patterns that warrants verification before pursuing opportunities tagged to this code.